17 Healthcare Stocks Moving In Friday's Pre-Market Session

Gainers

• CHF Solutions, Inc. CHFS shares moved upwards by 30.4% to $1.20 during Friday's pre-market session. The market cap seems to be at $3.8 million.
• BeiGene, Inc. BGNE shares surged 25.1% to $173.00. The most recent rating by Morgan Stanley, on October 11, is at Overweight, with a price target of $200.00.
• EyePoint Pharmaceuticals, Inc. EYPT stock increased by 9.3% to $2.47. The market cap stands at $203.5 million. The most recent rating by B. Riley, on September 24, is at Buy, with a price target of $4.00.
• Pulmatrix, Inc. PULM stock surged 6.8% to $0.89. The market cap stands at $16.0 million.
• Zai Lab, Inc. ZLAB shares surged 6.5% to $36.00. The market cap stands at $2.1 billion. According to the most recent rating by China Renaissance, on September 04, the current rating is at Buy.
• Advaxis, Inc. ADXS shares rose 5.8% to $0.34. The market cap stands at $6.1 million.
• Bionano Genomics, Inc. BNGO stock moved upwards by 5.1% to $0.83. The market cap stands at $7.8 million.
• Agile Therapeutics, Inc. AGRX stock surged 3.3% to $1.24. The market cap seems to be at $70.2 million.
• Guardion Health Sciences, Inc. GHSI stock surged 3.2% to $0.28. The market cap seems to be at $28.3 million.
• Lipocine, Inc. LPCN stock increased by 2.2% to $2.75. The market value of their outstanding shares is at $72.0 million.
• Qiagen, Inc. QGEN stock rose 2.2% to $30.44. The market value of their outstanding shares is at $7.4 billion. According to the most recent rating by Kepler Cheuvreux, on October 09, the current rating is at Reduce.
• Galapagos, Inc. GLPG shares increased by 2.1% to $187.88. The most recent rating by Morgan Stanley, on October 29, is at Overweight, with a price target of $193.00.
• Arbutus Biopharma, Inc. ABUS shares moved upwards by 2.1% to $1.45. The market cap stands at $90.1 million. According to the most recent rating by Chardan Capital, on October 04, the current rating is at Neutral.
• Nabriva Therapeutics, Inc. NBRV shares surged 2.1% to $1.97. The market cap seems to be at $146.7 million.

Losers

• Adamis Pharmaceuticals, Inc. ADMP stock decreased by 3.7% to $0.78 during Friday's pre-market session. The market cap stands at $43.2 million.
• Oncolytics Biotech, Inc. ONCY stock decreased by 2.4% to $1.22. The market value of their outstanding shares is at $19.0 million.
• Moleculin Biotech, Inc. MBRX shares declined 1.9% to $1.05. The market value of their outstanding shares is at $50.1 million. The most recent rating by Oppenheimer, on October 17, is at Outperform, with a price target of $2.00.